
Novel cancer therapy works for 73 per cent Indian patients in clinical trials: Why the Lancet report is significant
The clinical trial results of India’s first CAR T-cell therapy, published in The Lancet, show that it worked for nearly 73 per cent of patients.These results come from the Phase I and II trials of the therapy, where researchers assess its safety and …